[HTML][HTML] 直接口服抗凝剂在老年非瓣膜性房颤抗凝治疗有效性与安全性方面的最新进展
钟少正， 袁忠明 - Advances in Clinical Medicine, 2022 - hanspub.org
… and making individualized anticoagulation … that direct oral anticoagulants were superior to
warfarin in terms of effectiveness and safety. By comparing different direct oral anticoagulants, …
warfarin in terms of effectiveness and safety. By comparing different direct oral anticoagulants, …
[HTML][HTML] 非瓣膜性心房颤动口服抗凝药物临床应用研究进展
朱虹， 赵德斌， 施蕾， 李红 - Advances in Clinical Medicine, 2024 - hanspub.org
… (oral anticoagulant therapy, OAT)是NVAF高危患者缺血性卒中预防的基石.目前,指南推荐将直接
口服抗凝药(direct oral anticoagulants, … 然而,口服抗凝药(oral anticoagulant, OAC)的应用存在…
口服抗凝药(direct oral anticoagulants, … 然而,口服抗凝药(oral anticoagulant, OAC)的应用存在…
非维生素K 拮抗剂口服抗凝药治疗房颤的新进展
杨洁， 王晓明 - 心脏杂志, 2019 - heartj.cn
… Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from
ENGAGE AF-TIMI 48[J]. Eur Heart J Acute … Efficacy and safety of direct oral anticoagulants …
ENGAGE AF-TIMI 48[J]. Eur Heart J Acute … Efficacy and safety of direct oral anticoagulants …
[PDF][PDF] 肾功能衰竭患者心房颤动的抗凝治疗进展
王凯， 刘元生， 高伟波， 朱继红 - 中国血液净化, 2018 - cjbp.org.cn
… 凝药物,已有证据表明直接口服抗 凝剂(direct oral anticoagulants,DOACs)比华法 林能更好的预防
… A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis …
… A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis …
Temporal trends in ischemic stroke and anticoagulation therapy for non‐valvular atrial fibrillation: effect of diabetes: 非瓣膜性心房颤动患者缺血性脑卒中以及抗凝治疗的 …
… avoid confounding of the data by newer oral anticoagulants. Patients with Medicare as the
… coronary heart disease (from 53.5% to 50.9%; P < 0.001) and congestive heart failure (from …
… coronary heart disease (from 53.5% to 50.9%; P < 0.001) and congestive heart failure (from …
左心耳封堵术与口服抗凝药物应用于心房颤动患者有效性及安全性的meta 分析
任艳霞， 安智晶， 张得梅， 郭雪娅 - 上海交通大学学报(医学版), 2021 - xuebao.shsmu.edu.cn
… Heart disease and stroke statistics—2010 update: a report from the American Heart … Left
atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial …
atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial …
口服抗凝剂在非瓣膜性房颤伴慢性肾功能不全患者中的应用进展
李欣， 刘璐， 柳志红， 赵智慧， 罗勤， 赵青 - 协和医学杂志, 2022 - xhyxzz.pumch.cn
… Abstract: Oral anticoagulants can effectively reduce the risk of … However, all the non-vitamin
K antagonist oral anticoagulants … the administration of oral anticoagulants in these patients to …
K antagonist oral anticoagulants … the administration of oral anticoagulants in these patients to …
非瓣膜性房颤并急性缺血性卒中抗凝治疗时机
卢凤民， 吴冬燕 - 中国现代神经疾病杂志, 2024 - journal11.magtechjournal.com
… Heart disease and stroke statistics, 2015 update: a report … Early initiation of direct oral
anticoagulants after onset of stroke … " rule for starting direct oral anticoagulants after ischemic …
anticoagulants after onset of stroke … " rule for starting direct oral anticoagulants after ischemic …
[PDF][PDF] 不同日剂量新型口服抗凝药治疗冠状动脉粥样硬化性心脏病安全性与有效性的Meta 分析
赵紫楠， 张亚同， 胡欣 - 临床药物治疗杂志, 2020 - lcywzlzz.com
… dose of new oral anticoagulation (NOAC)in coronary atherosclerotic heart disease(CHD)…
, NOAC)在冠状动脉粥样硬化性心脏病(coronary ath⁃ erosclerotic heart disease,CHD)患者二…
, NOAC)在冠状动脉粥样硬化性心脏病(coronary ath⁃ erosclerotic heart disease,CHD)患者二…
心房颤动合并慢性肾脏疾病患者口服抗凝的治疗策略
张卫芳， 熊爱珍， 程晓曙 - 临床心血管病杂志, 2019 - lcxxg.whuhzzs.com
… Abstract: Oral anticoagulants(OACs) have been widely used in patients with atrial
fibrillation(AF) who have moderate or high risk of thromboembolism to reduce stroke and systemic …
fibrillation(AF) who have moderate or high risk of thromboembolism to reduce stroke and systemic …